|Articles|September 1, 2019
- Pharmaceutical Executive-09-01-2019
- Volume 39
- Issue 9
Pharmaceutical Executive, September 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec's 18th Annual Industry Auditover 6 years ago
Product Development: The Optimizer’s Curseover 6 years ago
Setting Your Launch Pathover 6 years ago
Pre-launch Prep: The Modern Protocolover 6 years ago
The Murky Outlook for Generic Drugsover 6 years ago
Post-Launch Birthday: The Time to Refineover 6 years ago
Product Launch: Five Paths Forwardalmost 7 years ago
Once Upon a Brandalmost 7 years ago
Country Report: Chinaalmost 7 years ago
Other Products to WatchAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5